| 666288 |
FRONTIERS IN ONCOLOGY |
A Clinicogenetic Prognostic Classifier for Prediction of Recurrence and Survival in Asian Breast Cancer Patients |
2021-03-17 |
10.3389/fonc.2021.645853 |
Chen Ting-Hao, Wei Jun-Ru, Lei Jason, Chiu Jian-Ying, Shih Kuan-Hui |
| 666287 |
FRONTIERS IN ONCOLOGY |
Spinal Epidural Cavernous Hemangiomas: A Clinical Series of 9 Cases and Literature Review |
2021-03-17 |
10.3389/fonc.2021.572313 |
Zhao Liyan, Jiang Yining, Wang Yubo, Bai Yang, Sun Ying, Li Yunqian |
| 666286 |
FRONTIERS IN ONCOLOGY |
Editorial: Genomics of Lymphoproliferative Disease |
2021-03-17 |
10.3389/fonc.2021.660016 |
Maura Francesco, Agnelli Luca, Bortoluzzi Stefania |
| 666285 |
FRONTIERS IN ONCOLOGY |
Evaluation of 18F-FMISO PET and 18F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy |
2021-03-17 |
10.3389/fonc.2021.606210 |
Lee Sze Ting, Tebbutt Niall, Gan Hui Kong, Liu Zhanqi, Sachinidis John, Pathmaraj Kunthi, Scott Andrew Mark |
| 666284 |
FRONTIERS IN ONCOLOGY |
LncRNA POU3F3 Contributes to Dacarbazine Resistance of Human Melanoma Through the MiR-650/MGMT Axis |
2021-03-17 |
10.3389/fonc.2021.643613 |
Wu Kai, Wang Qiang, Liu Yu-Lin, Xiang Zhuo, Wang Qing-Qing, Yin Li, Liu Shun-Li |
| 666283 |
FRONTIERS IN ONCOLOGY |
Harnessing the Metabolic Vulnerabilities of Leukemia Stem Cells to Eradicate Acute Myeloid Leukemia |
2021-03-17 |
10.3389/fonc.2021.632789 |
Kumar Bijender |
| 666282 |
FRONTIERS IN ONCOLOGY |
Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer |
2021-03-17 |
10.3389/fonc.2021.655856 |
Xie Xiao-Hong, Zhan Ze-Jiang, Qin Yin-Yin, Jiang Ju-Hong, Yin Wei-Qiang, Zheng Rong-Hui, Li Shi-Yue, Zhou Cheng-Zhi |
| 666281 |
FRONTIERS IN ONCOLOGY |
Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma |
2021-03-17 |
10.3389/fonc.2021.604784 |
Liu Guohong, Yuan Chunjue, Ma Jiaojiao, Pan Yunbao, Xu Haibo |
| 666280 |
FRONTIERS IN ONCOLOGY |
The Prognostic Significance of ZNF384 Fusions in Adult Ph-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: A Comprehensive Cohort Study From a Single Chinese Center |
2021-03-17 |
10.3389/fonc.2021.632532 |
Qin Ya-Zhen, Jiang Qian, Xu Lan-Ping, Wang Yu, Jiang Hao, Dao Feng-Ting, Chen Wen-Min, Zhao Xiao-Su, Liu Yan-Rong, Zhang Xiao-Hui, Liu Kai-Yan, Huang Xiao-Jun |
| 666279 |
FRONTIERS IN ONCOLOGY |
In Comparison to PSA, Interim Ga-68-PSMA PET/CT Response Evaluation Based on Modified RECIST 1.1 After 2nd Cycle Is Better Predictor of Overall Survival of Prostate Cancer Patients Treated With 177Lu-PSMA |
2021-03-17 |
10.3389/fonc.2021.578093 |
Prasad Vikas, Huang Kai, Prasad Sonal, Makowski Marcus R., Czech Norbert, Brenner Winfried |
